Adventist Health System of West v. Abbvie Inc.
United States Court of Appeals for the Ninth CircuitMarch 17, 202624-2180California4,917 words
Opinion
Opinion
Desai, J.
FOR PUBLICATION
UNITED STATES COURT OF APPEALS
FOR THE NINTH CIRCUIT
United States of America ex rel. No. 24-2180
ADVENTIST HEALTH SYSTEM OF
WEST, Relator, on behalf of the State D.C. No. 2:21-cv- of California and other States, 04249-DSF-SK
Plaintiff - Appellant,
OPINION
v.
ABBVIE INC.; ALLERGAN SALES,
LLC; ALLERGAN USA, INC.;
ASTRAZENECA, LP;
ASTRAZENECA
PHARMACEUTICALS, LP;
NOVARTIS PHARMACEUTICALS
CORPORATION; SANDOZ GROUP
AG; GENZYME CORPORATION;
SANOFI US SERVICES INC.;
SANOFI-AVENTIS U.S. LLC;
NOVARTIS AG; SANOFI S.A.,
Defendants - Appellees.
Appeal from the United States District Court for the Central District of California Dale S. Fischer, District Judge, Presiding Submitted April 10, 2025* Pasadena, California
Filed March 17, 2026
Before: Consuelo M. Callahan, Roopali H. Desai, and Ana de Alba, Circuit Judges.
Opinion by Judge Desai
SUMMARY**
False Claims Act
The panel reversed the district court’s dismissal for failure to state a claim and remanded for further proceedings in a qui tam action brought by Adventist Health System of West, asserting violations of the False Claims Act and state law analogues…